<?xml version="1.0" encoding="UTF-8"?>
<p>The primary approach for combating emergent diseases, particularly viral diseases, is proactive, targeted antiviral prophylaxis (CDC 
 <xref ref-type="bibr" rid="CR4">2006</xref>; WHO 
 <xref ref-type="bibr" rid="CR40">2007b</xref>). Unfortunately, the constantly changing antigenic characteristics of viruses, particularly all influenza viruses, reduce efficacy of vaccinations (WHO 
 <xref ref-type="bibr" rid="CR38">2006c</xref>). Moreover a myriad of technological issues pose serious hurdles to manufacturing and distribution of even small volumes of H5N1 vaccines (WHO 
 <xref ref-type="bibr" rid="CR38">2006c</xref>). Furthermore, intercontinental migration of birds and international human travels further exacerbate effective containment and mitigation of epidemics.
</p>
